Mesoblast Limited (ASX:MSB)
2.210
+0.060 (2.79%)
Apr 29, 2026, 3:29 PM AEST
Mesoblast Employees
Mesoblast had 81 employees as of June 30, 2025. The number of employees increased by 8 or 10.96% compared to the previous year.
Employees
81
Change (1Y)
8
Growth (1Y)
10.96%
Revenue / Employee
1.21M AUD
Profits / Employee
-1.75M AUD
Market Cap
2.79B
Employees Chart
Mesoblast News
- 5 hours ago - Mesoblast Achieves Patient Recruitment Target in Pivotal Phase 3 Trial for Chronic Low Back Pain - GlobeNewsWire
- 13 days ago - Mesoblast Acquires CAR Technology From Mayo Clinic To Enhance MSC Therapies - Nasdaq
- 14 days ago - Mesoblast Secures Exclusive CAR-MSC Technology License; Stock Up - Nasdaq
- 14 days ago - Mesoblast (MESO) Secures Global License for Advanced CAR Technology - GuruFocus
- 14 days ago - Mesoblast Acquires Chimeric Antigen Receptor (CAR) Platform Technology for Precision-Enhanced Cell Products - GlobeNewsWire
- 18 days ago - Mesoblast Receives IND Clearance From FDA to Directly Proceed to Registrational Trial for Approval of Ryoncil® in Duchenne Muscular Dystrophy - CORRECTION - GlobeNewsWire
- 20 days ago - Mesoblast (MESO) Gains on FDA Clearance for Duchenne Therapy Study - GuruFocus
- 20 days ago - Mesoblast Ltd Investor Day Transcript - GuruFocus